[Diagnosis of cancer. Signs, staging and prognosis].
作者信息
Boyle Helen, Droz Jean-Pierre
机构信息
Universite Claude-Bernard-Lyon-1, Lyon.
出版信息
Rev Prat. 2008 Apr 30;58(8):899-908.
PMID:18630833
Abstract
摘要
相似文献
1
[Diagnosis of cancer. Signs, staging and prognosis].[癌症的诊断。体征、分期及预后]
Rev Prat. 2008 Apr 30;58(8):899-908.
2
[Diagnosis of cancer. Signs and paraclinical investigations; stratification; prognosis].[癌症的诊断。体征与辅助检查；分层；预后]
Rev Prat. 2003 Mar 15;53(6):647-56.
3
The monitoring of minimal residual disease in patients with malignant tumors.恶性肿瘤患者微小残留病的监测。
Bull Soc Sci Med Grand Duche Luxemb. 1989 Mar-Apr;126(1):5-15.
4
The monitoring of minimal residual disease in patients with malignant tumors.恶性肿瘤患者微小残留病的监测。
Suppl J Med Oncol Tumor Pharmacother. 1988;1:5-15.
5
The importance of the differentiating syndromes for the efficacy assessment of Chinese medicine in the treatment of cancer.辨证论治对中医药治疗癌症疗效评估的重要性。
Chin J Integr Med. 2010 Feb;16(1):6-8. doi: 10.1007/s11655-010-0006-2. Epub 2010 Feb 4.
6
Tumour markers.肿瘤标志物
Br J Hosp Med. 1994;51(6):297-303.
7
[Cytokine gene].[细胞因子基因]
Rinsho Byori. 2002 Nov;Suppl 123:149-55.
8
Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome.蛋白质组学与转化医学：用于癌症诊断、预后及治疗结果预测的分子生物标志物
Expert Rev Proteomics. 2011 Feb;8(1):1-4. doi: 10.1586/epr.10.108.
9
[The importance of immunohistochemistry in histological diagnosis].[免疫组织化学在组织学诊断中的重要性]
Rev Med Suisse Romande. 1990 Jul;110(7):597-602.
10
[Clinical presentation of lung cancer].[肺癌的临床表现]
Nihon Rinsho. 2002 May;60 Suppl 5:141-4.
Zotero 插件